Unibios Holdings (Greece) Market Value

BIOSK Stock  EUR 3.00  0.06  2.04%   
Unibios Holdings' market value is the price at which a share of Unibios Holdings trades on a public exchange. It measures the collective expectations of Unibios Holdings SA investors about its performance. Unibios Holdings is trading at 3.00 as of the 28th of July 2025, a 2.04% up since the beginning of the trading day. The stock's open price was 2.94.
With this module, you can estimate the performance of a buy and hold strategy of Unibios Holdings SA and determine expected loss or profit from investing in Unibios Holdings over a given investment horizon. Check out Unibios Holdings Correlation, Unibios Holdings Volatility and Unibios Holdings Alpha and Beta module to complement your research on Unibios Holdings.
Symbol

Please note, there is a significant difference between Unibios Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Unibios Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unibios Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Unibios Holdings 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Unibios Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Unibios Holdings.
0.00
04/29/2025
No Change 0.00  0.0 
In 2 months and 31 days
07/28/2025
0.00
If you would invest  0.00  in Unibios Holdings on April 29, 2025 and sell it all today you would earn a total of 0.00 from holding Unibios Holdings SA or generate 0.0% return on investment in Unibios Holdings over 90 days. Unibios Holdings is related to or competes with Athens Medical, Karelia Tobacco, Eurobank Ergasias, Profile Systems, Interlife General, As Commercial, and Logismos Information. Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment systems in Europe More

Unibios Holdings Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Unibios Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Unibios Holdings SA upside and downside potential and time the market with a certain degree of confidence.

Unibios Holdings Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Unibios Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Unibios Holdings' standard deviation. In reality, there are many statistical measures that can use Unibios Holdings historical prices to predict the future Unibios Holdings' volatility.
Hype
Prediction
LowEstimatedHigh
0.153.007.46
Details
Intrinsic
Valuation
LowRealHigh
0.163.107.56
Details
Naive
Forecast
LowNextHigh
0.063.147.59
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.632.232.83
Details

Unibios Holdings Backtested Returns

Unibios Holdings is risky given 3 months investment horizon. Unibios Holdings owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.27, which indicates the firm had a 0.27 % return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.2% are justified by taking the suggested risk. Use Unibios Holdings Coefficient Of Variation of 371.23, semi deviation of 0.9384, and Risk Adjusted Performance of 0.2172 to evaluate company specific risk that cannot be diversified away. Unibios Holdings holds a performance score of 20 on a scale of zero to a hundred. The entity has a beta of 1.04, which indicates a somewhat significant risk relative to the market. Unibios Holdings returns are very sensitive to returns on the market. As the market goes up or down, Unibios Holdings is expected to follow. Use Unibios Holdings potential upside, and the relationship between the total risk alpha and kurtosis , to analyze future returns on Unibios Holdings.

Auto-correlation

    
  0.76  

Good predictability

Unibios Holdings SA has good predictability. Overlapping area represents the amount of predictability between Unibios Holdings time series from 29th of April 2025 to 13th of June 2025 and 13th of June 2025 to 28th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Unibios Holdings price movement. The serial correlation of 0.76 indicates that around 76.0% of current Unibios Holdings price fluctuation can be explain by its past prices.
Correlation Coefficient0.76
Spearman Rank Test0.9
Residual Average0.0
Price Variance0.1

Unibios Holdings lagged returns against current returns

Autocorrelation, which is Unibios Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Unibios Holdings' stock expected returns. We can calculate the autocorrelation of Unibios Holdings returns to help us make a trade decision. For example, suppose you find that Unibios Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Unibios Holdings regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Unibios Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Unibios Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Unibios Holdings stock over time.
   Current vs Lagged Prices   
       Timeline  

Unibios Holdings Lagged Returns

When evaluating Unibios Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Unibios Holdings stock have on its future price. Unibios Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Unibios Holdings autocorrelation shows the relationship between Unibios Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in Unibios Holdings SA.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Unibios Stock

Unibios Holdings financial ratios help investors to determine whether Unibios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Unibios with respect to the benefits of owning Unibios Holdings security.